Skip to content

A study to evaluate the rate of occurrence, causes, treatment and outcome of sepsis in Asian Intensive care units.

Prevalence, causes, management, and outcomes of sepsis in Asiaâ??s intensive care units - MOSAICS II Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/016898
Enrollment
2000
Registered
2019-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A419- Sepsis, unspecified organism

Interventions

Intervention1: NIL: NIL Control Intervention1: Nil: Nil

Sponsors

Asian Critical Care Clinical Trial Group
Lead Sponsor
Not Any
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.All adult patients who are admitted to the participating ICUs from 0000Hr (midnight) to 2359Hr (midnight) of the day of data collection for sepsis.They can be patients admitted from the emergency departments, or transferred from anywhere in the same hospital or other hospitals or elsewhere. 2.All adult patients who were admitted for sepsis to the participating ICUs prior to the day of data collection and who are still in the participating ICUs on the day of data collection.

Exclusion criteria

Exclusion criteria: 1.Patients younger than 18 years old. 2.Neurosurgical patients, defined as patients who are admitted to the ICU after or pending neurosurgical interventions. 3.Cardiac patients, defined as patients who are admitted to the ICU after cardiac surgery, for acute myocardial infarction without shock or respiratory failure, and for arrhythmias.

Design outcomes

Primary

MeasureTime frame
1. Prevalence, cause and outcome of sepsis in Asian Intensive Care Units 2.All-cause in-hospital mortality 3.All-cause ICU mortality. 4.Length of ICU stay. 5.Length of total hospital stay.Timepoint: We will follow all patients till hospital discharge, death in the ICU/hospital, and up to 90 days post-enrolment, whichever was earliest

Secondary

MeasureTime frame
1.time to management of sepsis with a focus on recommendations by the Surviving Sepsis Campaign guidelinesTimepoint: for total 4 days 0000Hr (midnight) to 2359Hr (midnight) of the day of data collection for sepsis for study duration of 1 year;2.To compare the prevalence, causes, outcomes, and management of sepsis in Asian ICUs in high, middle, and low-income countries and regions, defined according to the World Bank classification.Timepoint: for total 4 days 0000Hr (midnight) to 2359Hr (midnight) of the day of data collection for sepsis for study duration of 1 year;3.To specifically study the prevalence and outcomes of sepsis as a result of malaria, dengue, tuberculosis, cholera, and Salmonella infections, as well as culture-negative sepsis.Timepoint: for total 4 days 0000Hr (midnight) to 2359Hr (midnight) of the day of data collection for sepsis for study duration of 1 year

Countries

Bangladesh, China, Hong Kong, India, Indonesia, Iran (Islamic Republic of), Japan, Malaysia, Pakistan, Philippines, Republic of Korea, Saudi Arabia, Singapore, Taiwan, Thailand, Viet Nam

Contacts

Public ContactDr Sheila Nainan Myatra

Tata Memorial Center

sheila150@hotmail.com09820156070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 12, 2026